Eberhard Karls Universität Tübingen

“For me, it's just a piece of freedom”—Increased empowerment through physical activity promotion among socially disadvantaged women (2022) Sauter A, Herbert-Maul A, Abu-Omar K, Thiel A, Ziemainz H, Frahsa A, Linder S, Herrmann-Johns A Journal article A MeerKAT, e-MERLIN, HESS, and Swift search for persistent and transient emission associated with three localized FRBs (2022) Chibueze JO, Caleb M, Spitler L, Ashkar H, Schüssler F, Stappers BW, Venter C, et al. Journal article Occurrence and Severity of Venous Air Embolism During Neurosurgical Procedures: Semisitting Versus Supine Position (2022) Konrad FM, Mayer AS, Serna-Higuita LM, Hurth H, Tatagiba M, Reutershan J, Rosenberger P, Drexler B Journal article The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics (2022) Onurl OA, Wolff-Menzler C, Von Arnim CAF, Jessen F, Fink GR, Wiltfang J, Laske C, et al. Journal article Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis (2022) Krach F, Wheeler EC, Regensburger M, Börstler T, Wend H, Vu AQ, Wang R, et al. Journal article, Original article Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation (2022) Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, Wehrfritz A, et al. Journal article Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERDND): Time to Move Beyond the Skin (2022) Cordts I, Oender D, Traschuetz A, Kobeleva X, Karin I, Minnerop M, Koertvelyessy P, et al. Journal article Competence orientation in sport: a taxonomy for physical education (2022) Toepfer C, Hapke J, Liebl S, Sygusch R Journal article Evidence for γ-ray emission from the remnant of Kepleras supernova based on deep H.E.S.S. observations (2022) Aharonian F, Benkhali FA, Angüner EO, Ashkar H, Backes M, Martins VB, Batzofin R, et al. Journal article Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article